Search Results for 'patients relapsed'
patients relapsed published presentations and documents on DocSlides.
Recurrent Follicular Lymphoma
by sherrill-nordquist
With a Short First Remission:. How Aggressive Sho...
How I treat relapsed childhood acute
by trish-goza
lymphoblastic leukemia. Â . Franco Locatelli, Ma...
Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?
by mitsue-stanley
Bertrand Coiffier. Service d. ’. Hématologie. ...
Improving Therapy Outcomes in Relapsed/Refractory
by celsa-spraggs
Hodgkin Lymphoma. Program Objectives. Brentuximab...
Activity Faculty Scott C. Howard, MD,
by tatiana-dople
MSc. University of Tennessee College of . Health ...
Ro le of Stem Cell Transplant in Patients with Peripheral T-Cell
by sylvia
Lymphoma and Response to Treatment Strategies . IN...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
x0000x0000 xAttxachexd xBottxom xBBoxx
by evans
Chimeric Antigen Receptor Tcell TherapyClinical Gu...
Pivotal Safety and Efficacy Results From TRANSCEND NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel in Relapsed/Refractory (R/R) Large B-Cell Lymphomas
by botgreat
Lisocabtagene. . Maraleucel. in Relapsed/Refract...
A Phase Ib Dose Escalation Trial of SAR650984 (Anti-CD-38 mAb) in Combination with Lenalidomide and
by scoopulachanel
Myeloma. 1. Safety and Efficacy of Daratumumab wit...
Ibrutinib for Hairy Cell Leukemia
by pasty-toler
. A Brief Update of an Ongoing Trial. Jeff Jones...
Chronic lymphocytic leukemia,
by natalia-silvester
New agents timing?. Agne Paner, MD. Assistant pro...
Case Discussion A 64-year old woman diagnosed with monoclonal
by faustina-dinatale
Case Discussion A 64-year old woman diagnosed wit...
CAR-T Therapy in non-Hodgkin lymphomas
by natalie
Jonathon B. Cohen, MD. Dept of . Hematology. /Medi...
Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref
by willow
Meletios Dimopoulos,. 1. Hang Quach,. 2. Maria-V...
AFM13 in Combination with Allogeneic Natural Killer Cells (AB-101) in Relapsed or Refractory Hodgki
by cesar673
+. Peripheral T-Cell Lymphoma: A Phase 2 Study (L...